WHO ICTRP trial
A comparison of therapeutic effects of teicoplanin versus vancomycin in patients…
IRCT2016022220592N4 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2016022220592N4 |
|---|---|
| Public title | A comparison of therapeutic effects of teicoplanin versus vancomycin in patients admitted to the Intensive Care Unit after cardiac surgery |
| Scientific title | A comparison of therapeutic effects of teicoplanin versus vancomycin in patients admitted to the Intensive Care Unit after cardiac surgery because of MRSA infectious endocarditis in Masih Daneshvari hospital between years 2012-2016 |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Endocarditis. Acute endocarditis, unspecified;Acute endocarditis, unspecified |
| Interventions | Intervention 1: Intenvention : Teicoplanin, Teicoplanin was used by intravenous and intramuscular injection and single dose daily. Intervention 2: Control: Vancomycin, Initial Vancomycin dose was 1500 mg every 12 hours until serum… |
| Registration date | Jun 21, 2016 |
| Target size | 46 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: